Role of melatonin in immunity, aging and cancer: Therapeutic intervention

Drugs of Today

Volumn 33, Issue 1, 1997, Pages 25-39

  Pahlavani, Mohammad A ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MELATONIN;

AGING; CANCER; HUMAN; IMMUNITY; PINEAL BODY; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030938966     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (153)

1. Lerner, A.B., Case, J.D., Takahashi, Y., Lee, T.H., Mori, N. Isolation of melatonin, a pineal factor that lightens melanocytes. J Am Chem Soc 1958, 80: 2587-92.
2. Reiter, R.J. (Ed.). The Pineal Gland. Raven Press: New York 1984.
3. Preslock, J.P. The pineal gland: Basic and clinical correlations. Endocrinol Rev 1984, 5: 282-97.
4. Gershon, M.D. Biochemistry and physiology of serotonergic transmission. In: Handbook of Physiology, Section I. The Nervous System, Vol. 1, Part 1. Brookhart, J.M., Mountcastle, V.B. (Eds.). American Physiological Society: Bethesda, MD 1977, 573-623.
5. Axelrod, J., Fraschini, F., Axelrod, J. (Eds.). The Pineal Gland and its Neuroendocrine Role. Plenum Press: New York 1982.
6. Pangerl, B., Pangerl, A., Reiter, R.J. Circadian variations of adrenergic receptors in the mammalian pineal gland: A review. J Neurol Transm 1990, 81: 17-30.
7. Mikuni, M. Saito, Y, Koyama, T., Yamashita, I. Circadian variation of cyclic AMP in the rat pineal gland. J Neurochem 1981, 36: 1295-7.
8. Chik, C.I., Ho, A.K. Multiple regulation of cyclic nucleotides in rat pinealocytes. Prog Biophys Mol Biol 1989, 53: 197-203.
9. Klein, D.C., Weller, J.L. Indole metabolism in pineal gland: A circadian rhythm in N-acetyltransferase. Science 1970, 169: 1093-5.
10. Cogburn, L.A., Wilson, S., Letcher, L.R. Influence of pinealectomy on plasma and extrapineal melatonin rhythms in young chicken. Gen Comp Endocrinol 1987, 68: 343-56.
11. Lewy, A J., Tstsuo, M., Markey, S.P., Goodwin, F.K., Kopin, J. Pinealectomy abolishes plasma melatonin in rats. J Clin Endocrinol Metab 1980, 50: 204-5.
12. Ozaki, Y., Lynck, H.J. Presence of melatonin in plasma and urine of pinealectomized rats. Endocrinology 1976, 99: 641-4.
13. Vaughan, G.M., Reiter, R.J. Pineal dependence of the Syrian hamster's nocturnal serum melatonin surge. J Pineal Res 1986, 3: 9-14.
14. Neuwelt, E.A., Mickey, B., Lewy, A.J. The importance of melatonin and tumor markers in pineal tumors. J Neural Transm 1986, 21 (Suppl.): 397-423.
15. Mowak, J.Z., Zurawska, E., Zawilska, J. Melatonin and its generating system in vertebrate retina: Circadian rhythm, effect of environmental lighting and interaction with dopamine. Neurochemistry 1989, 14: 397-406.
16. Olcese, J., Moller, M. Characterization of serotonin N-acetyltransferase activity in the retina of the mongolian gerbil. Neurosci Lett 1989, 102: 235-40.
17. Weichmann, A.F. Melatonin: Parallels in pineal gland and retina. Exp Eye Res 1968, 42: 507-27.
18. Biesalski, H.K., Welker, H.A., Talman, R., Vollrath, L. Melatonin and other serotonin derivatives in the pineal pig membranous cochlea. Neurosci Lett 1988, 91: 41-6.
19. Bubenik, G.A., Brown, G.M., Grota, L.J. Immunohistological localization of melatonin in the digestive system of the rats. Experientia 1977, 33: 662-3.
20. Mhatre, M.C., Van Jaarsveld, A.S., Reiter, R.J. Melatonin in the lacrimal gland: First demonstration and experimental manipulation. Biochem Biophys Res Commun 1988, 153: 1187-92.
21. Reiter, R.J., Richardson, B.A., Matthews, S.A., Lane, S.J., Ferguson, B.N. Rhythms in immunoreactive melatonin in the retina and Harderian gland of rats. Persistence after pinealectomy. Life Sci 1983, 32: 1129-36.
22. Grota, L.J., Holloway, W.R., Brown, G.M. 24-Hour rhythm of hypothalamic melatonin immunofluorescence correlates with serum and retinal melatonin rhythms. Neuroendocrinology 1982, 34: 363-8.
23. Finocchiaro, L.M., Arzt, E.S., Fernandez, S., Criscuolo, M., Finkelman, S., Nahmod, V. Serotonin and melatonin synthesis in peripheral mononuclear cells: Stimulation by interferon-gamma as a part of an immunomodulatory pathway. J Interferon Res 1988, 8: 705-16.
24. Finocchiaro, L.M., Callebert, J., Launay, J.M., Jallon, J.M. Melatonin biosynthesis in Drosophila: Its nature and its effects. J Neurochem 1988, 50: 382-7.
25. Vivien, B., Pevet, P., Dubots, M.P., Arendt, J., Brown, G.M. Immunohistochemical evidence for the presence of melatonin in the pineal gland, the retina and the Harderian gland. Cell Tissue Res 1981, 217: 105-15.
26. Yoshizawas, Y., Wakabayshi, K., Shinozawa, T. Inhibition of planarian regeneration by melatonin. Hydrobiologica 1991, 227: 31-40.
27. Aschoff, J. (Ed.). Biological Rhythms. Handbook of Behavioral Neurobiology, Vol. 4. Plenum: New York 1981.
28. Van Gool, W.A., Mirmiran, M. Aging and circadian rhythm. In: Aging of the Brain and Alzheimer's Disease. Progress in Brain Research, Vol. 70. Swaab, D.F., Fliers, E., Mirmiran, M., Van Gool, W.A., Van Haaren, F. (Eds.). Elsevier: Amsterdam 1986, 255-77.
29. Ho, A.K., Gorta, L.J., Brown, G.M. Relationship between pineal N-acetyltransferase activity, pineal melatonin and serum melatonin in rats under different lighting conditions. Neuroendocrinology 1984, 39: 465-70.
30. Kennaway, D.J., Rowe, S. Melatonin binding sites and their role in seasonal reproduction. J Reprod & Fertil 1995, 49 (Suppl.): 423-35.
31. Chesworthm, M.J., Cassone, V.M., Armstrong, S.M. Effects of daily melatonin injections on activity rhythms of rats in constant light. Am J Physiol 1987, 253: 101-7.
32. Arendt, J., Aldhous, M., Wright, J. Synchronization of a disturbed sleep-wake cycle in a blind man by melatonin treatment. Lancet 1988, i: 772-3.
33. 33. Arendt, J., Aldhous, M., English, J. et al. Some effects of jet-lag and their alleviation by melatonin. Ergonomics 1987, 30: 1379-93.
34. 34. Maestroni, G.J., Pierpaoli, W. Pharmacological control of the hormonally mediated immune response. In: Psychoneuroimmunology. Ader, R. (Ed.). Academic Press: New York 1981, 405-25.
35. Maestroni, G.M., Conti, A., Pierpaoli, W. Role of the pineal gland in immunity: Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effects of corticosterone. J Neuroimmunol 1986, 13: 19-30.
36. Maestroni, G.J., Conti, A., Pierpaoli, W. Role of the pineal gland in Immunity. II. Melatonin enhances the immunity response via an opiatergic mechanism. Clin Exp Immunol 1987, 68: 384-91.
37. Maestroni, G.J., Conti, A., Pierpaoli, W. The pineal gland and the circadian opiatergic immunoregulatory role of melatonin. Ann NY Acad Sci 1987, 496: 67-77.
38. Maestroni, G.J., Conti, A., Pierpaoli, W. Pineal melatonin, its fundamental immunoregulatory role in aging and cancer. Ann NY Acad Sci 1988, 521: 140-8.
39. Maestroni, G.J., Conti, A., Pierpaoli, W. Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism. Immunology 1988, 63: 465-9.
40. Del Gobbo, V., Libri, V., Villani, N., Callio, R., Nistico, G. Pinealectomy inhibits interleukin-2 production and natural killer activity in mice. Int J Immunopharmacol 1989, 11: 567-77.
41. Lissoni, P., Tancini, G., Rovelli, F., Cattaneo, G., Archili, C., Barni, S. Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients. Br J Cancer 1990, 62: 838-9.
42. Maestroni, G.J. The immunoendocrine role of melatonin. J Pineal Res 1993, 14: 1-10.
43. Guerero, J.M., Reiter, R.J. A brief survey of pineal gland-immune system interrelationships. Endocrinol Res 1992, 18: 91-113.
44. Maestroni, G.J. T-helper-2 lymphocytes as a peripheral target of melatonin. J Pineal Res 1995, 18: 84-9.
45. Becker, J., Veit, G., Handgretinger, R. et al. Circadian variations in the immunomodulatory role of the pineal gland. Neuroendocrinol Lett 1998, 10: 65-72.
46. Vermulen, M., Palermo, M., Giordano, M. Neonatal pinealectomy impairs murine antibody-dependent cellular cytotoxicity. J Neuroimmunol 1993, 43: 97-101.
47. Finocchiaro, L.E., Nahmod, E., Launay, J.M. Melatonin biosynthesis and metabolism in peripheral blood mononuclear leukocytes. Biochem J 1991, 280: 727-32.
48. Vaughan, M.K., Hubbard, G.B., Champney, T.H., Vaughan, G.M., Little, J.C., Reiter, R.J. Splenic hypertrophy and extramedullary hematopoiesis induced in male syrian hamsters by short photoperiod or melatonin injections and reversed by melatonin pellets or pinealectomy. Am J Anat 1987, 179: 131-6.
49. Reichlin, S. Neuroendocrine-immune interactions. New Engl J Med 1993, 329: 1246-53.
50. Gaillard, R.C. Neuroendocrine-immune system interactions. The immune-hypothalamo-pituitary-adrenal axis. Trends Endocrinol Metab 1994, 5: 303-9.
51. Blalock, J.R. A molecular basis for biodirectional communication between the immune and the endocrine systems. Physiol Rev 1989, 69: 1-32.
52. Blalock, J.R. The syntax of immune-neuroendocrine communication. Immunol Today 1994, 15: 504-11.
53. Calvo, J.R., Fafii, M., Pozo, D., Guerrero, J.M. Immunomodulatory role of melatonin: Specific binding sites in human and rodent lymphoid cells. J Pineal Res 1995, 18: 119-26.
54. 125I]iodomelatonin by spleen membrane preparations of chicken. J Pineal Res 1992, 12: 167-73.
55. 125I]iodomelatonin binding sites in spleens of guinea pigs. Life Sci 1992, 50: 1719-26.
56. 125I]iodomelatonin by rats splenocytes. Characterization and its role on regulation of cyclic AMP production. J Neuroimmunol 1995, 57: 171-8.
57. 125I]Iodomelatonin binding sites in the bursa of Fabricius of birds: Binding characteristics, subcellular distribution, diurnal variations and age studies. J Endocrinol 1993, 138: 51-7.
58. Lopez, M.A., Calvo, J.R., Osuna, C., Guerrero, J.M. Interaction of melatonin with human lymphocytes: Evidence for binding sites coupled to potentiation of cyclic AMP stimulated vasoactive intestinal peptide and activation of cyclic GMP. J Pineal Res 1992, 12: 97-104.
59. 125I]iodomelatonin by rat thymus membranes during postnatal development. Immunol Lett 1993, 36: 59-64.
60. Blask, D.E. The pineal: An oncostatic gland? In: The Pineal Gland. Reiter, R.J. (Ed.). Raven Press: New York 1984, 253-84.
61. Csaba, G., Barath, P. Morphological changes of thymus and the thyroid gland after postnatal extirpation of the pineal body. Endocrinol Exp 1975, 9: 59-67.
62. Del Gobbo, V., Libri, V., Villani, N., Callio, R., Nistico, G. Pinealectomy inhibits interleukin-2 production and natural killer activity in mice. Int J Immunopharmacol 1989, 11: 567-77.
63. Kuci, S., Becker, J., Veit, G. Circadian variations of the immunomodulatory role of the pineal gland. Neuroendocrinol Lett 1983, 10: 65-79.
64. Sainz, R.M., Mayo, J.C., Uria, H. et al. The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J Pineal Res 1995, 19: 178-88.
65. Caroleo, M.C., Doria, G., Nistico, G. Melatonin restores immunodepression in aged and cyclophosphamide-treated mice. Ann NY Acad Sci 1994, 719: 343-52.
66. Pioli, C., Caroleo, M.C., Nistico, G., Doria, D. Melatonin increases antigen presentation and amplifies specific and nonspecific signals for T cell proliferation. Int J Immunopharmacol 1993, 15: 463-9.
67. Morrey, M.K., McLachlan, J.A., Serkin, D.C., Bakouche, O. Activation of human monocytes by the pineal neurohormone melatonin. J Immunol 1994, 153: 2671-80.
68. Karasek, M., Liberski, P., Radek, J., Bartkowiak, J. Influence of melatonin on the proliferation of hepatoma cells in the Syrian hamster. In vivo and in vitro study. Pineal Res 1992, 13: 107-12.
69. Provincialli, M., Stefano, G., Bulian, D., Tibaldi, A., Fabris, N. Effect of melatonin and pineal grafting on thymocyte apoptosis in aging mice. Mech Ageing Dev 1996, 90: 1-7.
70. Pahlavani, M.A., Harris, M.D. Effect of mitogen-induced lymphocyte proliferation and cytokine production in young and old F344 rats. Cell Immunol 1996, submitted.
71. Reiter, R.J., Richardson, B.A., Johnson, L.Y., Ferguson, B.N., Dinh, D.T. Pineal melatonin rhythm: Reduction in aging Syrian hamsters. Science 1980, 210: 1372-3.
72. Pang, S.F., Tang, F., Tang, P.L. Negative correlation of age and the level of pineal melatonin, pineal NAT and serum melatonin in male rats. J Exp Zool 1984, 229: 41-7.
73. Sack, R.L., Lewey, A.J., Erb, D.L., Vollmer, W.M., Singer, C.M. Human melatonin production decreases with age. J Pineal Res 1986, 3: 379-88.
74. Waldhauser, F.,. Waldhauser, M. Melatonin in aging. In: Melatonin: Clinical Perspectives. Miles, A., Philbrick, D.R.S., Thompson, C. (Eds.). Oxford University Press: Oxford 1988, 174-89.
75. Mirmiran, M., Swaab, D.F., Witing, W., Honnebier, M., Van Gool, W.A., Eikelenboom, P. Biological clocks in development, aging, and Alzheimer's disease. Brain Dysfunct 1989, 2: 57-66.
76. Nair, N.V., Hariharasubramanian, N., Pilapil, C., Issac, I., Thavundayil, J.X. Plasma melatonin. An index of brain aging in humans? Biol Psychiatry 1986, 21: 141-50.
77. Swaab, D.F., Fliers, E., Partiman, T.S. The suprachiasmatic nucleus of the human brain in relation to sex, age, and senile dementia. Brain Res 1985, 342: 37-44.
78. Gupta, D., Attanasio, A., Reiter, R.J. (Eds.). The Pineal Gland and Cancer. Brain Research Promotion: London 1988.
79. Anisimov, V.N., Reiter, R.J. The function of the pineal gland in cancer and aging. Vopr Onkol 1990, 36: 259-68.
80. Reuss, S., Olcese, J., Vollrath, L. Electrophysiological and endochnological aspects of aging in the rat pineal gland. Neuroendocrinology 1986, 43: 466-70.
81. Reuss, S., Spies, C., Schroder, H.J., Vollrath, L. The aged pineal gland: Reduction in pinealocyte number and adrenergic innervation in rats. Exp Gerontol 1990, 25: 183-8.
82. Greenberg, L.H., Weiss, B. Neural and hormonal modulation of adrenergic receptors in aging. In: Altered Endocrine Status During Aging. Alan R. Liss, Inc.: New York 1989, 57-60.
83. Dax, E.M., Sugden, D. Age-associated changes in pineal adrenergic receptors and melatonin synthesizing enzymes in the Wistar rat. J Neurochem 1988, 50: 468-72.
84. Mcintyre, I.M., Oxenkrug, G.F. Effect of aging on melatonin synthesis induced by 5-hydroxytryptophan and constant light in rats. Prog Neuro-Psycopharmacol Biol Psychiatry 1991, 15: 561-6.
85. Malm, O.J., Skaug, O.E., Lingjaerde, P. The effect of pinealectomy on bodily growth, survival rate and 32-P uptake in the rat. Acta Endocrinol 1959, 30: 22-8.
86. Maestroni, G.M., Conti, A., Pierpaoli, W. Melatonin, stress and the immune system. Pineal Res Rev 1989, 7: 203-26.
87. Anisimov, V.N. Bandarenko, L.A., Khavinson, V.K. The pineal peptides: Interaction with indoles and the role in aging and cancer. In: Neuroendocrinology: New Frontiers. Gupta, D., Wollmann, H.A., Ranke, M.B. (Eds.). Brain Research Promotion: London 1990, 317-25.
88. Dilman, V.M., Anisimov, V.N., Ostroumova, M.N., Khavinson, V.K., Morozov, V.G. Increase in life span of rats following polypeptide pineal extract treatment. Exp Pathol 1979, 17: 539-45.
89. Slepushkin, V.D., Anisimov, V.N., Khavinson, V.K., Morozov, V.G., Vasiliev, V.N., Kosykh, V.A. The pineal gland, immunity and cancer (theoretical and clinical aspects). Tomsk University Press: Tomsk 1990.
90. Pierpaoli, W., Yi, C., Dallara, A. Aging-postponing effects of circadian melatonin: Experimental evidence, significance, and possible mechanisms. Int J Neurosci 1990, 51: 339-40.
91. Grad, B., Kral, V.A. The effects of senescence on the resistance to stress. I. Response of young and old mice to cold. J Gerontol 1957, 12: 172-81.
92. Pierpaoli, W., Maestroni, J.M. Melatonin. A principal neuroimmunoregulatory and anti-stress hormone: Its anti-aging effects. Immunol Lett 1987, 16: 355-62.
93. Pierpaoli, W., Regelson, W. Pineal control of aging: Effect of melatonin and pineal grafting on aging mice. Proc Natl Acad Sci USA 1994, 91: 787-91.
94. Turek, F.W. Melatonin hype hard to swallow. Nature 1996, 379: 295-6.
95. Masoro, E.J., McCarter, J.R. Dietary restriction as a probe of mechanisms of senescence. Ann Rev Gerontol 1990, 183-97.
96. Masoro, E.J., Shimokawa, I., Higami, Y., McMahan, C.A., Yu, B.P. Temporal pattern of food intake not a factor in the retardation of aging processes by dietary restriction. J Gerontol 1995, 50A: B48-53.
97. Weindruch, R., Walford, R.L., Fligiel, S., Guthrie, D. The retardation of aging in mice by dietary restriction: Longevity, cancer, immunity and lifetime energy intake. J Nutr 1996, 116: 641-8.
98. Pahlavani, M.A., Haley-Zitlin, V., Richardson, A. Influence of dietary restriction on gene expression: Changes in the transcription of specific genes. In: Modulation of the Aging Process by Dietary Restriction. Yu, B.P. (Ed.). CRC Press: Boca Raton 1994, 143-56.
99. Stokkan, K.A., Reiter, R.J., Nonaka, K.O., Lerchl, A., Yu, B.P., Vaughan, M.K. Food restriction retards aging of the pineal gland. Brain Res 1991, 545: 66-72.
100. Henden, T., Stokkan, K.A., Reiter, R.J., Nonaka, K.O., Lerchl, A., Jones, D.J. The age-associated reduction in pineal beta-adrenergic receptor density is prevented by life-long food restriction in rats. Biol Signals 1992, 1: 34-9.
101. Bartsch, C., Bartsch, H., Fluchter, S., Mecke, D., Lippert, T. Diminished pineal function coincides with disturbed circadian endocrine rhythmicity in untreated primary cancer patients. Ann NY Acad Sci 1994, 719: 502-25.
102. Lapin, V. Pineal gland and malignancy. Osterreich Zeitsch Onko 1976, 3: 1-60.
103. Barone, R.M., Abe, R., Das Gupta, T.K. Pineal ablation in methylcholantherene-induced fibrosarcomas. Surg Forum 1972, 23: 115-6.
104. Das Gupta, T.K. Influence of pineal gland on the growth and spread of melanoma in hamsters. Cancer Res 1968, 19: 83-4.
105. Stanberry, L.R., Das Gupta, T.K., Seattle, C.W. Photoperiodic control of melanoma growth in hamsters: Influence of pinealectomy and melatonin. Endocrinology 1983, 113: 469-75.
106. Tamarkin, L., Cohen, M., Roselle, D. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenzanthracene induced mammary tumor in the rats. Cancer Res 1981, 41: 432-6.
107. Blask, D.E., Hill, S.M. Melatonin and cancer: Basic and clinical aspects. In: Melatonin: Clinical Aspects. Miles, A., Philbrick, D.R., Thompson, C. (Eds.). Oxford University Press: Oxford 1988, 128-73.
108. Bartsch, H., Bartsch, C., Simon, W.E., Flehmig, B., Ebels, I., Lippert, T.H. Antitumor activity of the pineal gland: Effect of unidentified substances vs. the effect of melatonin. Oncology 1992, 49: 27-30.
109. Dilman, V.M., Anisimov, V.N., Ostroumova, M.N., Morozova, V.G., Khavinson, V.K. Study of anti-tumor effect of polypeptide pineal extract. Oncology 1979, 36: 274-80.
110. Lissoni, P., Barni, S., Gazzaniga, M. et al. Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 alone. Oncology 1994, 51: 344-7.
111. Conti, A., Maestroni, G.M. The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res 1995, 10: 103-10.
112. Lissoni, P., Tisi, E., Barni, S. et al. Biological and clinical results of a neuroimmunotherapy with IL-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer. Br J Cancer 1992, 66: 155-8.
113. Lissoni, P., Barni, S., Crispino, S., Tancini, G., Fraschini, F. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur J Cancer Clin Oncol 1989, 25: 789-92.
114. Neri, B., Fiorelli, C., Moroni, F. et al. Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. Cancer 1994, 73: 3015-9.
115. Lissoni, P., Barni, S., Ardizzoia, A. et al. Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to first-line chemotherapy containing cisplatin. Oncology 1992, 49: 336-9.
116. Lissoni, P., Barni, S., Rovelli, F. et al. Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose IL-2 and melatonin: Preliminary results. Eur J Cancer 1993, 29A: 185-9.
117. Lissoni, P., Barni, S., Tancini, G. et al. Immunotherapy with subcutaneous low-dose IL-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract. Br J Cancer 1993, 67: 1404-7.
118. Lissoni, P., Barni, S., Meregalli, S. et al. Modulation of cancer endocrine therapy by melatonin: A phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 1995, 71: 854-6.
119. Lissoni, P., Barni, S., Ardizzoia, A., Tancini, G., Conti, A., Maestroni, G.J. A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms. Cancer 1994, 73: 699-701.
120. Lissoni, P., Barni, S., Toma, D. et al. The pineal hormone melatonin as a second line therapy in metastatic non-small-cell lung cancer resistant to chemotherapy. Acta Oncol 1990, 11: 41-4.
121. Starr, K.W. Growth and new growth: Environmental carcinogens in the process of human ontogeny. Prog Clin Cancer 1970, 4: 1-29.
122. Blask, D.E., Hill, S.M. Effects of melatonin on cancer: Studies on MCF-7 human breast cancer cells in culture. J Neural Transm 1986, 21 (Suppl.): 433-47.
123. Kelly, R.W., Amato, F., Seamark, R.F. N-Acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin is a potent inhibitor of prostaglandin biosynthesis. Biochem Biophys Res Commun 1984, 54: 114-6.
124. Lissoni, P., Barni, S., Tancini, G., Fossati, V., Frigerio, F. Pineal-opioid system interactions in the control of immunoinflammatory responses. Ann NY Acad Sci 1994, 741: 191-6.
125. Wanebo, H.J., Pace, R., Hargett, S., Katz, D., Sando, J. Production of and response to IL-2 in peripheral blood lymphocytes of cancer patients. Cancer 1986, 57: 655-62.
126. Lissoni P., Barni, S., Rovelli, F. et al. Correlation of serum IL-2 levels, soluble IL-2 receptors and T lymphocytes subsets in cancer patients. Tumori 1990, 76: 14-7.
127. O'Garra, A. Interleukins and the immune system. Lancet 1989, 1: 1003-5.
128. Grimm, E.A., Mazumder, A., Zhang, H.Z., Rosenberg, S.A. Lymphokine-activated killer cells. J Exp Med 1982, 155: 1823-41.
129. Kuribayashi, K., Gillis, S., Kern, D.E., Henny, C.S. Murine NK cell culture: Effect of IL-2 and interferon on cell growth and cytotoxic reactivity. J Immunol 1981, 126: 2321-7.
130. Smith, K.A. Interleukin-2: Inception, impact, and implication. Science 1980, 1169-76.
131. Lissoni, P., Barni, S., Tancini, G., Mainini, E., Piglia, F., Maestroni, G.M. Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin locally advanced or metastatic endocrine tumors. Oncology 1995, 52: 163-6.
132. Lissoni, P., Brivio, F., Ardizzoia, A., Tancini, G., Barni, S. Subcutaneous therapy with low-dose IL-2 plus neurohormone melatonin in metastatic gastric cancer patients with low performance status. Tumori 1993, 79: 410-4.
133. Lissoni, P., Barni, S., Rovelli, F. et al. Neuroendocrine effects of subcutaneous IL-2 injection in cancer patients. Tumori 1991, 77: 212-5.
134. Lissoni, P., Barni, S., Tancini, G. et al. A randomized study with subcutaneous low-dose IL-2 alone vs. IL-2 plus the pineal hormone melatonin in advanced solid neoplasm other than renal cancer and melanoma. Br J Cancer 1994, 69: 196-9.
135. Lissoni, P., Meregalli, S., Fossati, V. et al. A randomized study of immunotherapy with low-dose subcutaneous IL-2 plus melatonin vs. chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small lung cancer. Tumori 1994, 80: 464-7.
136. Barni, S., Lissoni, P., Cazzaniga, M. et al. Neuroimmunotherapy with subcutaneous low-dose IL-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinoma. Tumori 1992, 78: 383-7.
137. Aldeghi, R., Lissoni, P., Barni, S. et al. Low-dose IL-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma. Eur J Cancer 1994, 30A: 167-70.
138. Reiter, R.J., Melchiorri, D., Sewerynek, E. et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995, 18: 1-11.
139. Porggeler, B., Saarela, S., Reiter, R.J. et al. Melatonin. A highly potent endogenous radical scavenger and electron donor: New aspects of the oxidation chemistry of this indole accessed in vitro. Ann NY Acad Sci 1994, 741: 419-20.
140. Cagnoli, C.M., Atabay, C., Kharlamova, E., Manev, H. Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 1995, 18: 222-6.
141. 2-induced lipid peroxidation in homogenates of different rat brain regions. J Pineal Res 1995, 19: 51-6.
142. Reiter, R.J., Tan, D., Poeggeler, B., Menendez, A, Chen, L., Saarela, S. Melatonin as a free radical scavenger: Implications for aging and age-related diseases. Ann NY Acad Sci 1994, 741: 1-12.
143. Halliwell, B., Gutteridge, J.M. (Eds.). Free Radicals in Biology and Medicine, 2nd Edition. Clarendon Press: Oxford 1989.
144. Kehrer, J.P. Free radicals, a mediator of tissue injury and disease. Crit Rev Toxicol 1993, 23: 21-48.
145. Halliwell, B. Reactive oxygen species and the central nervous system. J Neurochem 1992, 59: 1609-23.
146. Halliwell, B., Gutteridge, J.M. (Eds.). Free Radicals in Biology and Medicine, 3rd Edition. Oxford Press: Oxford 1991.
147. Reiter, R.J., Tan, D., Poeggeler, B., Chen, L., Menendez, A. Melatonin, free radicals and cancer initiation. In: Advances in Pineal Research, Vol. 8. Maestroni, G.J., Conti, A., Reiter, R.J. (Eds.). John Libbey: London 1995.
148. Harmon, D. Free radical theory of aging. Mutat Res 1992, 275: 257-66.
149. Tan, D., Chen. L.D., Poeggeler, B., Manchester. L.C., Reiter, R.J. Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocrine J 1993, 1: 57-60.
150. Pieri, C., Marra, M., Moroni, F., Recchioni, R., Marcheselli, F. Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci 1994, 15: PL271-6.
151. 2+-dependent ATPase in cardiac sarcolemma. J Pineal Res 1993, 14: 178-83.
152. Kaneko, M., Beamish, R.E., Dhalla, N.S. Depression of heart sarcolemma calcium pumping ATPase activity by oxygen free radical. Am J Physiol 1989, 156: H368-74.
153. 2+-stimulated ATPase activity induced by alloxan. Am J Physiol 1994, 267: E57-62.